Metraipolis › archive › dc_eec9155383dc

VALID regimen of voriconazole optimizes therapeutic target attainment and minimizes adverse events in patients with liver dysfunction — Europe PMC PMID:42656781

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42656781
DOI: 10.3389/fphar.2026.1895947
License (as archived): solo-consultazione
Archived: 2026-10-08T02:42:12.585Z
SHA-256 of the archived text: fd0627d047a920c6b544c1f79ea2a03199b6473de85235375a2b7709a51c8365
Stable URL of this page: https://metraipolis.com/documento/dc_eec9155383dc

How to cite

VALID regimen of voriconazole optimizes therapeutic target attainment and minimizes adverse events in patients with liver dysfunction — Europe PMC PMID:42656781 — Europe PMC (en), https://europepmc.org/article/MED/42656781 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eec9155383dc (Metraipolis archive dc_eec9155383dc, sha256 fd0627d047a920c6b544c1f79ea2a03199b6473de85235375a2b7709a51c8365)

BibTeX

@misc{dceec9155383dc,
  title = {VALID regimen of voriconazole optimizes therapeutic target attainment and minimizes adverse events in patients with liver dysfunction — Europe PMC PMID:42656781},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42656781},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eec9155383dc; sha256 fd0627d047a920c6b544c1f79ea2a03199b6473de85235375a2b7709a51c8365},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42656781. Agents can read the archived copy with the MCP tool read_document.